Literature DB >> 22709355

The impact of epilepsy on sleep architecture during childhood.

Alessandra M Pereira1, Oliviero Bruni, Raffaele Ferri, Andre Palmini, Magda L Nunes.   

Abstract

PURPOSE: The effect of etiology on the relationship between epilepsy and sleep during childhood has not been studied in detail. The aim of this study was to evaluate differences in sleep structure in drug-resistant epilepsies with different underlying causes.
METHODS: We studied 31 patients with drug-resistant epilepsies with or without a structural lesion (lesional and nonlesional) and compared their sleep architecture with that of normal controls and with that of a group of children with benign epilepsy with rolandic spikes (BERS). Subjects underwent a single-night polysomnographic recording. Sleep recordings were scored according to the American Academy of Sleep Medicine (AASM) and cyclic alternating pattern (CAP) criteria. KEY
FINDINGS: Compared to normal controls, patients with drug-resistant epilepsy showed a significant reduction of time in bed, total sleep time, rapid eye movement (REM) sleep, sleep stage N3, and sleep efficiency, and a significant increase in wake after sleep onset. The lesional subgroup showed a reduction in total sleep time and sleep latency and an increase in REM latency and wake after sleep onset. No significant differences, however, were found comparing the lesional and nonlesional subgroups. When compared to BERS, patients with drug-resistant epilepsy showed a significant reduction in sleep stage N3, REM sleep, and sleep efficiency. Regarding CAP analysis, when compared to controls, the drug-resistant group had an increased A1% and a decreased A2%, with a decrease of A1 index in N3 and a global decrease of A2 and A3 indexes. The lesional subgroup showed a slight increase of A1% with a decrease of A1 index in N3 and a global decrease of A2 and A3 indexes. Drug-resistant epilepsy, compared to benign epilepsy showed an increase of CAP rate in N2 and of A1 index in N1 and N2 but not in N3; A2 and A3 indexes were similar in both, but patients with drug-resistant epilepsy showed a significant reduction of A3 index in N1. SIGNIFICANCE: Our findings suggest that the presence of structural cerebral abnormalities may play an important role in disrupting sleep architecture. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2012        PMID: 22709355     DOI: 10.1111/j.1528-1167.2012.03558.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  Sleep cyclic alternating pattern in otherwise healthy overweight school-age children.

Authors:  Rodrigo Chamorro; Raffaele Ferri; Cecilia Algarín; Marcelo Garrido; Betsy Lozoff; Patricio Peirano
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

2.  Developmental Trajectories of Sleep Problems from Childhood to Adolescence Both Predict and Are Predicted by Emotional and Behavioral Problems.

Authors:  Biyao Wang; Corinna Isensee; Andreas Becker; Janice Wong; Peter R Eastwood; Rae-Chi Huang; Kevin C Runions; Richard M Stewart; Thomas Meyer; L G Brüni; Florian D Zepf; Aribert Rothenberger
Journal:  Front Psychol       Date:  2016-12-01

Review 3.  The Bidirectional Relationship between Sleep and Immunity against Infections.

Authors:  Elizabeth G Ibarra-Coronado; Ana Ma Pantaleón-Martínez; Javier Velazquéz-Moctezuma; Oscar Prospéro-García; Mónica Méndez-Díaz; Mayra Pérez-Tapia; Lenin Pavón; Jorge Morales-Montor
Journal:  J Immunol Res       Date:  2015-08-31       Impact factor: 4.818

Review 4.  Polysomnographic Aspects of Sleep Architecture on Self-limited Epilepsy with Centrotemporal Spikes: A Systematic Review and Meta-analysis.

Authors:  Camila Dos Santos Halal; Bernardo Lessa Horta; Magda Lahorgue Nunes
Journal:  Sleep Sci       Date:  2017 Oct-Dec

5.  Overnight Video-Polysomnographic Studies in Children with Intractable Epileptic Encephalopathies.

Authors:  Natasa Nenadic-Baranasic; Romana Gjergja-Juraski; Ivan Lehman; Mirjana Turkalj; Boro Nogalo; Nina Barisic
Journal:  Med Sci Monit       Date:  2018-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.